Heterophilic NeuGcGM3 ganglioside cancer vaccine in advanced melanoma patients: Results of a phase Ib/IIa study

Title
Heterophilic NeuGcGM3 ganglioside cancer vaccine in advanced melanoma patients: Results of a phase Ib/IIa study
Authors
Keywords
-
Journal
CANCER BIOLOGY & THERAPY
Volume 7, Issue 4, Pages 488-495
Publisher
Informa UK Limited
Online
2010-12-29
DOI
10.4161/cbt.7.4.5476

Ask authors/readers for more resources

Find the ideal target journal for your manuscript

Explore over 38,000 international journals covering a vast array of academic fields.

Search

Ask a Question. Answer a Question.

Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.

Get Started